Lwin, Khin Maung <br/><br/>
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Mar 2012 
 - 1571-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.05877-11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antimalarials--administration & dosage<br/>Artemisinins--administration & dosage<br/>Chemoprevention<br/>Dietary Fats--administration & dosage<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Hematocrit<br/>Humans<br/>Malaria, Falciparum--parasitology<br/>Malaria, Vivax--parasitology<br/>Male<br/>Middle Aged<br/>Placebos<br/>Plasmodium falciparum--drug effects<br/>Plasmodium vivax--drug effects<br/>Quinolines--administration & dosage<br/>Risk<br/>Thailand